Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab visual field study in branch retinal vein occlusion
RBR-6brs8bPhase 4Not yet recruiting
- Sponsor
- Universidade Federal do Espírito Santo
- Start
- Sep 2016
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ranibizumab in branch retinal vein occlusion (BRVO), sponsored by Universidade Federal do Espírito Santo. Planned start Sep 2016; status: not yet recruiting.
02
Drugs
ranibizumab
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on RBR-6brs8b.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6brs8b.